媒体中心
媒体中心

媒体中心

Company News

Industry News

Download

Yantai Shunkang Biotechnology Co., Ltd. First Information Disclosure on Environmental Impact Assessment of Pharmaceutical Intermediate Product Production Projects

Yantai Shunkang Biotechnology Co., Ltd. First Information Disclosure on Environmental Impact Assessment of Pharmaceutical Intermediate Product Production Projects

2022-05-26

Project name: Yantai Shunkang Biotechnology Co., Ltd. Pharmaceutical Intermediate Product Production Project

26

2022

/

05

The first information disclosure of environmental impact assessment (stamped)

The first information disclosure of environmental impact assessment (stamped)

2022-05-26

Construction content: The site of this project is located at No. 2 Emei Road, Economic and Technological Development Zone, Laiyang City, Yantai City, Shandong Province, covering an area of 74,800 m, and the company plans a total construction area of 45,000m.The existing phase I project mainly builds three pharmaceutical chemical synthesis workshops, with an annual output of 100 tons of 12,3-tri-5-deoxy-B-D-ribose, 10 tons of L2-deoxyribose and 50 tons of 2-deoxy-D-ribose; the first phase of the project has been completed and put into operation.

26

2022

/

05

On November 9, 2020, the leaders of Yantai Science and Technology Bureau and Laiyang Science and Technology Bureau visited our company.

On November 9, 2020, the leaders of Yantai Science and Technology Bureau and Laiyang Science and Technology Bureau visited our company.

2020-11-10

On November 9, 2020, the leaders of Yantai Science and Technology Bureau and Laiyang Science and Technology Bureau visited our company.

10

2020

/

11

Qilu Pharmaceutical Co., Ltd.

Qilu Pharmaceutical Co., Ltd.

2020-09-03

Our company is a qualified supplier designated by Qilu Pharmaceutical Co., Ltd. and has established a long-term cooperative relationship. On September 1, 2020, four people from Qilu Pharmaceutical visited.

03

2020

/

09

Qualified supplier designated by Nanjing Luye Pharmaceutical Co., Ltd.

Qualified supplier designated by Nanjing Luye Pharmaceutical Co., Ltd.

2020-06-24

Our company is a qualified supplier designated by Nanjing Luye Pharmaceutical Co., Ltd. and has established a long-term cooperative relationship. On June 24, 2020, Nanjing Luye Pharmaceutical and a group of three people visited.

24

2020

/

06

< 12 >

SAF Coolest v1.3 设置面板HFYSX-ZOIA-EDSWE-ASE

图片ALT信息： Sikon Biotech

无数据提示

Sorry, the current column has no content for the time being.!

You can view other columns or returnHome Page

SVG图标库请自行添加图标，用div包起来，并命名使用